Niki BioSolutions, Inc. (NIKI) Long-Term Deferred Tax (2017 - 2023)
Niki BioSolutions' (NIKI) quarterly Long-Term Deferred Tax came in at $17.4 million in Q4 2023, up 10.07% YoY from $15.8 million in Q4 2022, and up 2826.52% on a QoQ basis from $594807.0 in Q2 2023.
Niki BioSolutions, Inc. (NIKI) Long-Term Deferred Tax (2017 - 2023) Analysis & Trends
Niki BioSolutions (NIKI) has 7 years of Long-Term Deferred Tax data on file, last reported at $17.4 million in Q4 2023.
- Quarterly Long-Term Deferred Tax rose 10.07% year-over-year to $17.4 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $17.4 million (up 10.07% YoY) and the FY2023 annual result came in at $17.4 million, up 10.07% from the prior year.
- Long-Term Deferred Tax advanced to $17.4 million in Q4 2023, from $594807.0 in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $17.4 million in Q4 2023 to a low of $594807.0 in Q2 2023.
- A 5-year average of $10.5 million and a median of $11.4 million in 2020 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2019 — Long-Term Deferred Tax surged 101.45% — and 2023, when it increased 10.07%.
- Tracing NIKI's Long-Term Deferred Tax over 5 years: stood at $6.2 million in 2019, then surged by 61.88% to $10.0 million in 2020, then grew by 29.41% to $12.9 million in 2021, then advanced by 22.7% to $15.8 million in 2022, then climbed by 10.07% to $17.4 million in 2023.
- The last three Long-Term Deferred Tax figures came in at $17.4 million (Q4 2023), $594807.0 (Q2 2023), and $15.8 million (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 17.41 Mn |
| Jun 30, 2023 | 594,807.00 |
| Dec 31, 2022 | 15.81 Mn |
| Dec 31, 2021 | 12.89 Mn |
| Dec 31, 2020 | 9.96 Mn |
| Dec 31, 2019 | 6.15 Mn |
| Dec 31, 2018 | 3.05 Mn |
| Dec 31, 2017 | 1.25 Mn |